MicroRNA-24/MODY gene regulatory pathway mediates pancreatic β-cell dysfunction

Yunxia Zhu, Weiyan You, Hongdong Wang, Yating Li, Nan Qiao, Yuguang Shi, Chenyu Zhang, David Bleich, Xiao Han

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

Overnutrition and genetics both contribute separately to pancreatic β-cell dysfunction, but how these factors interact is unclear. This study was aimed at determining whether microRNAs (miRNAs) provide a link between these factors. In this study, miRNA-24 (miR-24) was highly expressed in pancreatic β-cells and further upregulated in islets from genetic fatty (db/db) or mice fed a high-fat diet, and islets subject to oxidative stress. Overexpression of miR-24 inhibited insulin secretion and β-cell proliferation, potentially involving 351 downregulated genes. By using bioinformatic analysis combined with luciferase-based promoter activity assays and quantitative real-time PCR assays, we identified two maturity-onset diabetes of the young (MODY) genes as direct targets of miR-24. Silencing either of these MODY genes (Hnf1a and Neurod1) mimicked the cellular phenotype caused by miR-24 overexpression, whereas restoring their expression rescued β-cell function. Our findings functionally link the miR-24/MODY gene regulatory pathway to the onset of type 2 diabetes and create a novel network between nutrient overload and genetic diabetes via miR-24.

Original languageEnglish (US)
Pages (from-to)3194-3206
Number of pages13
JournalDiabetes
Volume62
Issue number9
DOIs
StatePublished - Sep 1 2013
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'MicroRNA-24/MODY gene regulatory pathway mediates pancreatic β-cell dysfunction'. Together they form a unique fingerprint.

Cite this